Mode
Text Size
Log in / Sign up
N/A Completed N=29 Prevention

Engaging Suicidal Patients in Mental Health Treatment

Suicide · Depression · Mental Health Impairment · Suicidal Ideation
Source: ClinicalTrials.gov NCT05021224 ↗
Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcomePrimary: Acceptability of Intervention Measure (AIM) — 3.96; 4.40; 3.88; 3.34 score on a scale

Summary

The investigators will identify characteristics of suicidal patients who do or do not attend a first mental health visit following referral using administrative data. Then, the investigators will apply established approaches to contextual inquiry to identify barriers and facilitators to mental health treatment attendance for individuals at risk of suicide. Using established procedures from implementation science and behavioral economics, the investigators will then leverage the insights gleaned from Aims 1 and 2, relevant theories and frameworks, and the extant literature to develop preliminary strategies to support attendance at first mental health visit. Strategies will be developed in collaboration with a team of experts in suicide, implementation science, and behavioral economics. These preliminary strategies will then be iteratively tested and refined. The investigators also will assess putative mechanism using behavioral tasks and self-report tools.

Outcome Measures

OutcomeResultp-value
PRIMARY
Acceptability of Intervention Measure (AIM)
3.96; 4.40; 3.88; 3.34
PRIMARY
Intervention Appropriateness Measure (IAM)
3.88; 4.40; 4.00; 3.25
PRIMARY
Feasibility of Intervention Measure (FIM)
3.77; 4.30; 4.00; 3.16
PRIMARY
Attendance at First Mental Health Visit
5; 2; 0; 3; 6; 2

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • Elevated suicidal ideation per item 9 of the Patient Health Questionnaire (PHQ item score ≥ 1) completed during a primary care visit
  • Able to read and understand English

Exclusion Criteria

  • Current psychotic episode requiring emergency services and/or precluding ability to provide informed consent
  • Documented diagnosis of dementia in the past 2 years. The rationale for this criteria is that these individuals may have difficulty understanding the study information provided to them, including how to opt out of the study
  • No patients will be excluded on the basis of sex, race, or ethnicity
  • Primary care provider notes that participation is not indicated
  • Already received a study engagement strategy following a different primary care visit.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05021224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search